Staining solution for cataract surgeries available as vial and syringe

Industry updates

Staining solution  for cataract surgeries available as vial and syringe
Colin Kerr
Colin Kerr
Published: Sunday, January 1, 2017
[caption id="attachment_6216" align="alignnone" width="750"]Vioron staining solution Vioron staining solution[/caption] STAINING SOLUTION Vioron is Geuder’s number one tissue staining solution for cataract surgeries, and is available as vial and syringe.“It consists of trypan blue and ensures an effective staining and thus brilliant visualisation of the anterior lens capsule,” said a company spokesman. “This staining solution enables an excellent distinction of the capsulorhexis margin. It is quick and easy to apply, and applicable to a variety of further indications, e.g. congenital or (hyper) mature cataract surgery,” added the spokesman. www.geuder.com EXPANDED CUSTOMER REACH HOYA has announced a definitive agreement to acquire Performance Optics, including its subsidiaries VISION EASE and Daemyung Optical. Performance Optics is a global ophthalmic lens manufacturer specialising in polycarbonate, photochromic, polarised and high-index eyeglass lenses. “The acquisition of Performance Optics expands HOYA’s customer reach, particularly through VISION EASE’s presence in the Americas and its strengths in polycarbonate products and technologies,” said Girts Cimermans, CEO of HOYA Vision Care. “Performance Optics provides HOYA with additional capabilities,” he added. www.hoya.com NEW APPOINTMENT Carl Zeiss Meditec has appointed Steven C Schallhorn MD as Chief Medical Officer for Global Ophthalmic Devices, consisting of refractive lasers, surgical ophthalmology and ophthalmic diagnostics. Dr Schallhorn will serve on the Executive Leadership Team, providing strategic direction for the business and medical guidance on the clinical use of ZEISS’ portfolio of ophthalmic diagnostic and surgical technologies. The company said Dr Schallhorn will collaborate with key opinion leaders.
Tags: industry, new products, product updates
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...